Abstract
Background: Akathisia continues to be a significant challenge in current neurological and psychiatric practice. Prompt and accurate detection is often difficult and there is a lack of consensus concerning the neurobiological basis of akathisia. No definitive treatment has been established for akathisia despite numerous preclinical and clinical studies.]
Method: We reviewed antipsychotic-induced akathisia including its clinical presentation, proposed underlying pathophysiology, current and under investigation therapeutic strategies. Conclusion: Despite the initial promise that second generation antipsychotics would be devoid of akathisia effects, this has not been confirmed. Currently, there are limited therapeutic options for the clinical practice and the evidence supporting the most widely used treatments (beta blockers, anticholinergic drugs) is still absent or inconsistent.Keywords: Akathisia, antipsychotics, neuroleptics, movement disorders, agitation, anticholinergics, benzodiazepines, extrapyramidal signs.
Current Neuropharmacology
Title:Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges
Volume: 15 Issue: 5
Author(s): Haitham Salem, Caesa Nagpal, Teresa Pigott and Antonio Lucio Teixeira*
Affiliation:
- Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, McGovern Medical School. The University of Texas Health Science Center, Houston, Texas,United States
Keywords: Akathisia, antipsychotics, neuroleptics, movement disorders, agitation, anticholinergics, benzodiazepines, extrapyramidal signs.
Abstract: Background: Akathisia continues to be a significant challenge in current neurological and psychiatric practice. Prompt and accurate detection is often difficult and there is a lack of consensus concerning the neurobiological basis of akathisia. No definitive treatment has been established for akathisia despite numerous preclinical and clinical studies.]
Method: We reviewed antipsychotic-induced akathisia including its clinical presentation, proposed underlying pathophysiology, current and under investigation therapeutic strategies. Conclusion: Despite the initial promise that second generation antipsychotics would be devoid of akathisia effects, this has not been confirmed. Currently, there are limited therapeutic options for the clinical practice and the evidence supporting the most widely used treatments (beta blockers, anticholinergic drugs) is still absent or inconsistent.Export Options
About this article
Cite this article as:
Salem Haitham, Nagpal Caesa, Pigott Teresa and Teixeira Lucio Antonio*, Revisiting Antipsychotic-induced Akathisia: Current Issues and Prospective Challenges, Current Neuropharmacology 2017; 15 (5) . https://dx.doi.org/10.2174/1570159X14666161208153644
DOI https://dx.doi.org/10.2174/1570159X14666161208153644 |
Print ISSN 1570-159X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6190 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Roles of Renal Proximal Tubule Transport in the Pathogenesis of Hypertension
Current Hypertension Reviews Stable Angina Pectoris: Current Medical Treatment
Current Pharmaceutical Design Patent Selections
Recent Patents on Cardiovascular Drug Discovery Prevalence and Risk Factors of Vitamin D Deficiency in Critically Ill Patients
Inflammation & Allergy - Drug Targets (Discontinued) Treatment of the Cheyne-Stokes Breathing Pattern in Patients with Congestive Heart Failure: An Update
Current Respiratory Medicine Reviews Vasopressin & Oxytocin in Control of the Cardiovascular System: An Updated Review
Current Neuropharmacology Emergence in Pyrazolines: Synthetic and Biological Perspective
The Natural Products Journal Analgesic Efficacy and Safety of Spinal Oxycodone in Total Hip Arthroplasty: A Preliminary Study
Current Medicinal Chemistry Hurdles in the Drug Discovery of Cathepsin K Inhibitors
Current Topics in Medicinal Chemistry Pneumonia in the Elderly
Current Respiratory Medicine Reviews Antenatal Glucocorticoids Supplementation and Central Nervous System Development
Current Drug Metabolism Clinical Implications of Non-Invasive Measurement of Central Aortic Blood Pressure
Current Vascular Pharmacology Refractory Behçet’s Disease with Multi-organ Involvement - Learning from Failure
Current Rheumatology Reviews Doxorubicin: The Good, the Bad and the Ugly Effect
Current Medicinal Chemistry Safety Limits of Antidepressant Use Plus Combinations: Focus on Cardiovascular Function
Current Drug Metabolism Nicotinic Cholinergic System in the Hypothalamus Modulates the Activity of the Hypothalamic Neuropeptides During the Stress Response
Current Neuropharmacology Cardiovascular Pharmacogenomics
Current Pharmacogenomics and Personalized Medicine Role of Peroxynitrite in the Cardiovascular Dysfunction of Septic Shock
Current Vascular Pharmacology Therapeutic Potential of Targeting Protease Activated Receptors in Cardiovascular Diseases
Current Pharmaceutical Design Antiprotozoal Agents: An Overview
Anti-Infective Agents in Medicinal Chemistry